Gonzalo
López Montoya
Publications by the researcher in collaboration with Gonzalo López Montoya (19)
2023
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280
-
Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
Psychiatry Research, Vol. 323
-
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study
Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580
2022
-
A replication study of JTC bias, genetic liability for psychosis and delusional ideation
Psychological Medicine, Vol. 52, Núm. 9, pp. 1777-1783
-
Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway
Psychological Medicine, Vol. 52, Núm. 10, pp. 1910-1922
-
Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113
-
The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
European Neuropsychopharmacology, Vol. 63, pp. 47-59
2021
-
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543
-
Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e25
-
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study
Translational Psychiatry, Vol. 11, Núm. 1
2020
-
Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum
Epidemiology and Psychiatric Sciences
-
Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study
Psychological Medicine, Vol. 50, Núm. 11, pp. 1884-1897
-
The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme
Social Psychiatry and Psychiatric Epidemiology, Vol. 55, Núm. 5, pp. 645-657
2019
-
Assessing cross-national invariance of the Community Assessment of Psychic Experiences (CAPE)
Psychological Medicine, Vol. 49, Núm. 15, pp. 2600-2607
-
Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study
Schizophrenia bulletin, Vol. 45, Núm. 5, pp. 960-965
-
Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study
World Psychiatry, Vol. 18, Núm. 2, pp. 173-182
-
White noise speech illusions: A trait-dependent risk marker for psychotic disorder?
Frontiers in Psychiatry, Vol. 10, Núm. SEP
2018
-
Treated incidence of psychotic disorders in the multinational EU-GEI study
JAMA Psychiatry, Vol. 75, Núm. 1, pp. 36-46
2014
-
Identifying gene-environment interactions in schizophrenia: Contemporary challenges for integrated, large-scale investigations
Schizophrenia Bulletin, Vol. 40, Núm. 4, pp. 729-736